Ayar, YavuzSayılar, Emel IşıktaşYavuz, MahmutArslan, İsmailAksu, ÇiğdemAteş, CoşkunPektaş, FatihTüysüz, ÖzlemTopal, Naile BolcaDirican, Melahat2024-10-252024-10-252015-09-011302-0072https://doi.org/10.4274/Haseki.2043https://www.hasekidergisi.com/articles/an-enflammatory-marker-in-chronic-renal-failure-patients-visfatin/doi/Haseki.2043https://hdl.handle.net/11452/47055Aim: Visfatin is a cytokine released from adipose tissue, especially in enflammation. In our study, we tried to show the relationship of visfatin levels with chronic renal failure (CRF) as an enflammatory marker.Methods: We included 50 CRF patients (28 male, 22 female) who attended Uludag University Nephrology Clinic and 31 healthy volunteers (13 male, 18 female). Visfatin levels and biochemical parameters, such as parathyroid hormone (PTH), lipid parameters, albumin, C-reactive protein (CRP), creatinine, urea, immunoglobulins, etc. were examined.Results: In CRF patients, visfatin levels were found to be significantly increased (p<0.001) and albumin, hemoglobin, body mass index (BMI) and high density lipoprotein (HDL) cholesterol levels were decreased (p<0.001). Triglycerides (p=0.003), CPR (p=0.005), procalcitonin (p<0.001), IgG3 (p=0.003), and ferritin (p<0.001) levels were significantly higher in patient group than in control group as an enflammatory marker.Conclusion: CRF is an independent enflammatory process. Visfatin levels in patients with chronic renal failure patients are determined to be high as an indicator of enflammation.eninfo:eu-repo/semantics/openAccessAdipose-tissueEndothelial dysfunctionPlasma visfatinInflammationAssociationAtherosclerosisAdipocytokinesProcalcitoninExpressionDiseaseChronic renal failureVisfatinEnflammationGeneral & internal medicineArticle00021675550000218719153310.4274/Haseki.2043